Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Hancock, MD, Jan. 10, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) ...
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email